Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Cardinal Health (NY:CAH)

224.99 -0.59 (-0.26%)
Official Closing Price Updated: 7:00 PM EST, Feb 18, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Cardinal Health

< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
18 19 Next >
News headline image
3 Stocks to Buy at 52-Week Lows: March 4 Edition ↗
Sometimes a gem can get tossed in the trash, which is what you will find with these three stocks to buy at 52-week lows. 
Via InvestorPlace
News headline image
If You Invested $100 In This Stock 5 Years Ago, You Would Have $200 Today ↗
 
Via Benzinga
News headline image
Shake Shack, Cardinal Health And More: CNBC's 'Final Trades' ↗
On CNBC’s "Halftime Report Final Trades," Bryn Talkington of Requisite Capital Management said she likes Invesco S&P 500 Equal Weight Energy ETF (NYSE: 
Via Benzinga
Topics ETFs
News headline image
Dividend Income Update January 2024 ↗
It’s dividend income update time. One of my favorite times of the month as I get to review my previous month of passive income received from my dividend income portfolio 
Via Talk Markets
News headline image
Cardinal Health Stock Shows Healthy Improvement To Its Technical Strength ↗
On Wednesday, Cardinal Health stock got a positive adjustment to its Relative Strength (RS) Rating, from 69 to 78. 
Via Investor's Business Daily
News headline image
If You Invested $1000 In This Stock 5 Years Ago, You Would Have $2,100 Today ↗
 
Via Benzinga
News headline image
Earnings Preview: Cardinal Health ↗
 
Via Benzinga
News headline image
Here's How Much You Would Have Made Owning Cardinal Health Stock In The Last 5 Years ↗
 
Via Benzinga
News headline image
How Is The Market Feeling About Cardinal Health? ↗
 
Via Benzinga
News headline image
US Federal Trade Commission Investigates Drug Shortages Amid Allegations Of Market Manipulation ↗
FTC probes chemotherapy shortages, scrutinizing drug distributors and hospital groups. Root causes of drug shortages under scrutiny. Industry defends practices. 
Via Benzinga
News headline image
Why Is Healthcare Services Provider Cardinal Health Stock Trading Lower Today? ↗
Cardinal Health reports strong Q2 FY24 results: Adjusted EPS up 38% to $1.82, beating consensus. Q2 revenue for pharmaceutical segment rises 12% to $53.5 billion. Raised FY24 EPS guidance to... 
Via Benzinga
News headline image
Nasdaq Futures Rebound As Traders Eye Apple, Meta, Amazon Earnings: Analyst Flags 'January Barometer' That Bodes Well For The Year ↗
After ending January with modest gains, the major averages now look to earnings catalysts to drive momentum, with futures higher in first trading session of February. 
Via Benzinga
News headline image
Here's How Much $1000 Invested In Cardinal Health 5 Years Ago Would Be Worth Today ↗
 
Via Benzinga
News headline image
$1000 Invested In Cardinal Health 5 Years Ago Would Be Worth This Much Today ↗
 
Via Benzinga
News headline image
How Is The Market Feeling About Cardinal Health? ↗
 
Via Benzinga
News headline image
Earnings Scheduled For February 1, 2024 ↗
Companies Reporting Before The Bell • ING Groep (NYSE:ING) is expected to report earnings for its fourth quarter. • Shell (NYSE:SHEL) is likely to report quarterly earnings at $1.81 per share on... 
Via Benzinga
Cardinal Health Inc. (NYSE: CAH) Climbs to New 52-Week High
Via Investor Brand Network
News headline image
Tech Titans Microsoft, Apple Lead 'Magnificent Seven' Earnings Wave This Week: Can Mega-Caps Ignite Market Optimism? ↗
An analyst sees the Satya Nadella-led company's earnings to be the key barometer for AI spending. 
Via Benzinga
Topics Artificial Intelligence
News headline image
3 Top-Ranked Large-Caps To Buy For Growth ↗
Large-cap stocks are frequently targeted among investors. They typically have greater stability and a proven track record, two reasons why they're beloved. 
Via Talk Markets
News headline image
2023 Year-End Sector Review – Part 2 ↗
In this 2023 year-end sector review, we will take a look at what kind of year it was for healthcare, industrial, technology, materials, REITs, and utility sectors. Additionally, how is 2024 shaping up... 
Via Talk Markets
News headline image
Dow Resumes Selloff, Set To Snap Win Streak ↗
Stocks have resumed their trek lower in what has become an alarming trend to start 2024. 
Via Talk Markets
Topics Stocks
News headline image
What's Going On With Cardinal Health Shares Today? ↗
Cardinal Health Inc (NYSE: CAH) shares are trading lower by around 4% after the company provided an update on its FY24 outlook and ongoing portfolio review. 
Via Benzinga
News headline image
Will My Portfolio’s Top 3 Performing Stocks From 2023 Deliver Again in 2024? ↗
This stock expert takes a look at his portfolio's top performing stocks from the last year. 
Via InvestorPlace
News headline image
Best Performing Stocks In January Over The Last Two Decades (75%+ Win Rate) ↗
January is generally one of the weakest months of the year for the stock market, but the following stocks have excelled in January over the last 15 years or more. 
Via Talk Markets
News headline image
Wall Street's Top 10 Stock Calls This Week - Saturday, Dec. 16 ↗
What has Wall Street been buzzing about this week? Here are the top 5 buy calls and the top 5 sell calls made by Wall Street's best analysts during the week of Dec. 11-15. 
Via Talk Markets
News headline image
10 Health Care Stocks Whale Activity In Today's Session ↗
 
Via Benzinga
News headline image
3 No-Brainer Stocks to Buy in December ↗
These are no-brainer stocks to buy regardless of whether we are in a bull or bear market. Strong tailwinds continue to push them forward. 
Via InvestorPlace
News headline image
Becton Dickinson Recall Certain Infusion Pumps Due To Compatibility Issues With Cardinal Health's Monoject Syringes ↗
Friday, the FDA said that Becton, Dicki 
Via Benzinga
News headline image
Jim Cramer: Buy Shares Of This Personal Computer Giant, Wait For 'A Little Bit Of Pullback' ↗
On CNBC’s "Mad Money Lightning Round," Jim Cramer said he would not buy CRISPR Therapeutics AG (NASDAQ: CRSP) stock "all the way up here. 
Via Benzinga
News headline image
Jim Cramer Bullish On Boeing In Latest 'Lightning Round': 'This Is Their Year' ↗
Cramer's optimism about Boeing follows his previous praise for the company in April 2023, when he referred to it as "really incredible." 
Via Benzinga
< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
18 19 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.